Trial Information
Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma
Inclusion Criteria:
1. Patients diagnosed with liver cancer based on biopsy or serum AFP
level, associated with characteristic hypervascular liver tumors on triphasic spiral CT
scan or MRI.
2. Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or
nodular hyperplasia.
3. Patients with hepatitis B or hepatitis C viral infections not associated with liver
cancer.
Exclusion Criteria:No other patients except those listed above will be recruited.
Additionally, patients will be excluded if, upon looking through their medical records,
information required for data analysis are missing.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
identify mutations in the hepatitis B virus genome that predisposes these high risk individuals to the development of liver cancer
Outcome Description:
We will be using blood specimens collected through another protocol
Outcome Time Frame:
one time
Safety Issue:
No
Principal Investigator
Samuel So
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
HEP0013
NCT ID:
NCT00767936
Start Date:
March 2008
Completion Date:
December 2014
Related Keywords:
- Liver Cancer
- Hepatitis B
- Hepatitis C
- Hepatobiliary Cancers Liver
- Hepatobiliary Cancers
- Carcinoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Liver Neoplasms
- Carcinoma, Hepatocellular
Name | Location |
Stanford University School of Medicine |
Stanford, California 94305-5317 |